{"id":6163,"date":"2018-04-19T03:33:49","date_gmt":"2018-04-19T07:33:49","guid":{"rendered":"http:\/\/lifeinsurance-orleans.ca\/Life-Insurance-Blog\/?guid=661df4178238ee9b01bc3e26f6b03bae"},"modified":"2018-04-19T03:33:49","modified_gmt":"2018-04-19T07:33:49","slug":"novartis-1q-profit-jumps-12-per-cent-as-heart-drug-sales-soar","status":"publish","type":"post","link":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/2018\/04\/19\/novartis-1q-profit-jumps-12-per-cent-as-heart-drug-sales-soar\/","title":{"rendered":"Novartis 1Q profit jumps 12 per cent as heart drug sales soar"},"content":{"rendered":"<p>GENEVA &#8212; Swiss pharmaceuticals company Novartis says net income jumped 12 per cent in the first quarter, pointing to explosive growth in its heart-failure drug Entresto as its rollout continues, and powerful double-digit percentage growth for psoriasis drug Cosentyx.<\/p>\n<p>The Basel-based powerhouse, one of the world&#8217;s largest drug companies, said Thursday that first-quarter net profit under new CEO Vas Narasimhan rose to $2.03 billion when accounting for currency changes, up from $1.67 billion a year earlier.<\/p>\n<p>Net sales rose 4 per cent to $12.69 billion.<\/p>\n<p>Sales of Cosentyx jumped 35 per cent to $580 million, and Entresto sales soared 126 per cent to $200 million.<\/p>\n<p>Generics and biosimilars unit Sandoz saw U.S. sales drop 18 per cent amid competitive pressures.<\/p>\n<p>Novartis experienced double-digit percentage growth in emerging markets, largely due to an 18-per cent increase in sales in China.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>GENEVA &mdash; Swiss pharmaceuticals company Novartis says net income jumped 12 per cent in the first quarter, pointing to explosive growth in its heart-failure drug Entresto as its rollout continues, and powerful double-digit percentage growth for psoriasis drug Cosentyx. The Basel-based powerhouse, one of the world&rsquo;s largest drug companies, said Thursday that first-quarter net profit [&hellip;]<\/p>\n","protected":false},"author":578,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[],"tags":[],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts\/6163"}],"collection":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/users\/578"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/comments?post=6163"}],"version-history":[{"count":1,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts\/6163\/revisions"}],"predecessor-version":[{"id":6164,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/posts\/6163\/revisions\/6164"}],"wp:attachment":[{"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/media?parent=6163"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/categories?post=6163"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.lifeinsurance-orleans.ca\/index.php\/wp-json\/wp\/v2\/tags?post=6163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}